4.6 Article

Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit

Journal

CRITICAL CARE MEDICINE
Volume 39, Issue 11, Pages 2464-2469

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CCM.0b013e318225761a

Keywords

L-type fatty acid-binding protein; neutrophil gelatinase-associated lipocalin; interleukin 18; biomarker; acute kidney injury; mortality; mixed ICU

Funding

  1. MEXT, Japan [1200015, 21790795]
  2. Takeda Science Foundation, Japan
  3. Asahi Kasei Kuraray Medical Co, Ltd
  4. Takeda Science Foundation
  5. Promoting Science and Technologies MEXT
  6. Grants-in-Aid for Scientific Research [22790780, 21790795] Funding Source: KAKEN

Ask authors/readers for more resources

Objective: Biomarkers for detection of acute kidney injury and prediction of mortality will be useful to improve the outcomes of critically ill patients. Although several promising acute kidney injury biomarkers have been reported, evaluation in heterogeneous disease-oriented populations is necessary to confirm their reliability before their translation to clinical use. This study was undertaken to evaluate the reliability of new acute kidney injury biomarkers including urinary L-type fatty acid-binding protein with heterogeneous intensive care unit populations. Design: Prospective observational cohort study. Setting: Single-center study, 15-bed medical-surgical mixed intensive care unit at a university hospital. Patients: Three hundred thirty-nine adult critically ill patients who had been admitted to the intensive care unit were studied prospectively. Interventions: None. Measurements and Main Results: Five urinary biomarkers (L-type fatty acid-binding protein, neutrophil gelatinase-associated lipocalin, interleukin-18, N-acetyl-beta-D-glucosaminidase, and albumin) were measured at intensive care unit admission. By the RIFLE (Risk, Injury, Failure, Loss, End-stage kidney disease) criteria, 131 patients (39%) were diagnosed as acute kidney injury. Urinary L-type fatty acid-binding protein detected acute kidney injury better than the other biomarkers did (the area under the receiver operating characteristic curves for L-type fatty acid-binding protein 0.75, neutrophil gelatinase-associated lipocalin 0.70, interleukin-18 0.69, N-acetyl-beta-D-glucosaminidase 0.62, albumin 0.69). Urinary L-type fatty acid-binding protein predicted later-onset acute kidney injury after intensive care unit admission with the highest area under the receiver operating characteristic curve value of 0.70. Furthermore, L-type fatty acid-binding protein, neutrophil gelatinase-associated lipocalin, and interleukin-18 were able to predict 14-day mortality with higher area under the receiver operating characteristic curves than acute kidney injury detection (area under the receiver operating characteristic curve for L-type fatty acid-binding protein 0.90, neutrophil gelatinase-associated lipocalin 0.83, interleukin-18 0.83). The combination of L-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin improved mortality prediction (area under the receiver operating characteristic curve 0.93). Conclusion: This prospective observational study with a cohort of heterogeneous patients treated in a mixed intensive care unit revealed that new acute kidney injury biomarkers have a significantly and moderately predictive use for acute kidney injury diagnosis and that urinary L-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin can serve as new biomarkers of mortality prediction in critical care. (Crit Care Med 2011; 39: 2464-2469)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available